Literature DB >> 14660000

Expression of OP4 (ORL1, NOP1) receptors in vascular endothelium.

Filippo Granata1, Rossella Luisa Potenza, Anna Fiori, Roberto Strom, Brunella Caronti, Paola Molinari, Sonia Donsante, Gennaro Citro, Luisa Iacovelli, Antonio De Blasi, Richard T Ngomba, Guido Palladini, Francesca Passarelli.   

Abstract

Endothelial cells from rat brain microvessels, human aortic artery and human umbilical vein were examined, together with ex vivo rat brain capillaries and rat aortic ring sections, for the expression of opioid receptor-like OP-4 mRNA and protein. High levels of mRNA expression and an immunopositive reaction for the receptor protein were detected in the endothelial cells from primary and from established in vitro cultures, as well as in the intima of ex vivo rat aortic rings, where the signal was limited to the endothelial layer. Interaction of the OP4 receptor with its physiological ligand nociceptin caused, in cultured endothelial cells, the activation of a mitogen-activated protein (MAP) kinase cascade. Taken together, these results show that the OP4 receptor is synthesised and functionally expressed in endothelial cells, presumably as a starting point for some vasoactive mechanism(s).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14660000     DOI: 10.1016/j.ejphar.2003.09.049

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  ZP120 causes relaxation by pre-junctional inhibition of noradrenergic neurotransmission in rat mesenteric resistance arteries.

Authors:  U Simonsen; B E Laursen; J S Petersen
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

2.  Structural requirements of N-substituted spiropiperidine analogues as agonists of nociceptin/orphanin FQ receptor.

Authors:  Pingping Bao; Xiaole Zhang; Hong Ren; Yan Li; Zulin Mu; Shuwei Zhang; Guohui Li; Ling Yang
Journal:  Int J Mol Sci       Date:  2011-12-06       Impact factor: 5.923

Review 3.  Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.

Authors:  Catarina Chaves; Fernando Remiao; Salvatore Cisternino; Xavier Decleves
Journal:  Curr Neuropharmacol       Date:  2017-11-14       Impact factor: 7.363

4.  In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells.

Authors:  Mark F Bird; Barbara Gallacher-Horley; John McDonald; David G McVey; Fatin Al-Janabi; Remo Guerrini; Girolamo Calo; Shu Ye; Jonathan P Thompson; David G Lambert
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

5.  The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.

Authors:  Zoë L S Brookes; Emily N Stedman; Nicola J Brown; Christopher P Hebbes; Remo Guerrini; Girolamo Calo; Charles S Reilly; David G Lambert
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.